156 related articles for article (PubMed ID: 29396798)
1. The Involvement of Cytochrome c Oxidase in Mitochondrial Fusion in Primary Cultures of Neonatal Rat Cardiomyocytes.
Yin W; Li R; Feng X; James Kang Y
Cardiovasc Toxicol; 2018 Aug; 18(4):365-373. PubMed ID: 29396798
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy.
Zuo X; Xie H; Dong D; Jiang N; Zhu H; Kang YJ
Cardiovasc Toxicol; 2010 Sep; 10(3):208-15. PubMed ID: 20582486
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes.
Zuo X; Dong D; Sun M; Xie H; Kang YJ
PLoS One; 2013; 8(6):e67549. PubMed ID: 23818984
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor recovers suppressed cytochrome c oxidase activity by restoring copper availability in hypertrophic cardiomyocytes.
Sun M; Zuo X; Li R; Wang T; Kang YJ
Exp Biol Med (Maywood); 2014 Dec; 239(12):1671-7. PubMed ID: 25107896
[TBL] [Abstract][Full Text] [Related]
5. Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size.
Zhou Y; Jiang Y; Kang YJ
J Mol Cell Cardiol; 2008 Jul; 45(1):106-17. PubMed ID: 18495151
[TBL] [Abstract][Full Text] [Related]
6. Role of copper in regression of cardiac hypertrophy.
Zheng L; Han P; Liu J; Li R; Yin W; Wang T; Zhang W; Kang YJ
Pharmacol Ther; 2015 Apr; 148():66-84. PubMed ID: 25476109
[TBL] [Abstract][Full Text] [Related]
7. Copper chaperone for superoxide dismutase-1 transfers copper to mitochondria but does not affect cytochrome c oxidase activity.
Wang B; Dong D; Kang YJ
Exp Biol Med (Maywood); 2013 Sep; 238(9):1017-23. PubMed ID: 23900152
[TBL] [Abstract][Full Text] [Related]
8. Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway.
Zhou Y; Bourcy K; Kang YJ
Cardiovasc Res; 2009 Oct; 84(1):54-63. PubMed ID: 19542178
[TBL] [Abstract][Full Text] [Related]
9. MiR-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy.
Zhao Y; Ponnusamy M; Liu C; Tian J; Dong Y; Gao J; Wang C; Zhang Y; Zhang L; Wang K; Li P
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2871-2881. PubMed ID: 28782654
[TBL] [Abstract][Full Text] [Related]
10. Miro1 as a novel regulator of hypertrophy in neonatal rat cardiomyocytes.
Conejeros C; Parra V; Sanchez G; Pedrozo Z; Olmedo I
J Mol Cell Cardiol; 2020 Apr; 141():65-69. PubMed ID: 32234389
[TBL] [Abstract][Full Text] [Related]
11. The involvement of vimentin in copper-induced regression of cardiomyocyte hypertrophy.
Li R; Bourcy K; Wang T; Sun M; Kang YJ
Metallomics; 2015 Sep; 7(9):1331-7. PubMed ID: 26168186
[TBL] [Abstract][Full Text] [Related]
12. Cardiac cytochrome-c oxidase deficiency occurs during late postnatal development in progeny of copper-deficient rats.
Johnson WT; Brown-Borg HM
Exp Biol Med (Maywood); 2006 Feb; 231(2):172-80. PubMed ID: 16446493
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy.
Alvarez BV; Johnson DE; Sowah D; Soliman D; Light PE; Xia Y; Karmazyn M; Casey JR
J Physiol; 2007 Feb; 579(Pt 1):127-45. PubMed ID: 17124262
[TBL] [Abstract][Full Text] [Related]
14. A selective requirement for copper-dependent activation of cytochrome c oxidase by Cox17p.
Kako K; Takehara A; Arai H; Onodera T; Takahashi Y; Hanagata H; Ogra Y; Takagi H; Kodama H; Suzuki KT; Munekata E; Fukamizu A
Biochem Biophys Res Commun; 2004 Nov; 324(4):1379-85. PubMed ID: 15504366
[TBL] [Abstract][Full Text] [Related]
15. Phenylephrine Attenuated Sepsis-Induced Cardiac Inflammation and Mitochondrial Injury Through an Effect on the PI3K/Akt Signaling Pathway.
Li HM; Li KY; Xing Y; Tang XX; Yang DM; Dai XM; Lu DX; Wang HD
J Cardiovasc Pharmacol; 2019 Mar; 73(3):186-194. PubMed ID: 30839512
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of α-enolase protects cardiomyocytes from phenylephrine-induced hypertrophy.
Gao S; Liu XP; Wei LH; Lu J; Liu P
Can J Physiol Pharmacol; 2018 Apr; 96(4):352-358. PubMed ID: 28910549
[TBL] [Abstract][Full Text] [Related]
17. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophy induced KIF5B controls mitochondrial localization and function in neonatal rat cardiomyocytes.
Tigchelaar W; de Jong AM; Bloks VW; van Gilst WH; de Boer RA; Silljé HH
J Mol Cell Cardiol; 2016 Aug; 97():70-81. PubMed ID: 27094714
[TBL] [Abstract][Full Text] [Related]
19. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
20. Loss of function of Sco1 and its interaction with cytochrome c oxidase.
Stiburek L; Vesela K; Hansikova H; Hulkova H; Zeman J
Am J Physiol Cell Physiol; 2009 May; 296(5):C1218-26. PubMed ID: 19295170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
